Additionally, the regulatory mechanisms of CCR1 and its ligands in immune cells are believed to function similarly in MM cells, indicating that CCR1 contributes to physiological and pathological processes within the tumor microenvironment (TME) [68, 69]. This evidence concerns the gene CCR1 and Miyoshi myopathy.